These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
148 related articles for article (PubMed ID: 31986050)
1. Ketoconazole- Martin F; Pop M; Kacso I; Grosu IG; Miclăuş M; Vodnar D; Lung I; Filip GA; Olteanu ED; Moldovan R; Nagy A; Filip X; Bâldea I Mol Pharm; 2020 Mar; 17(3):919-932. PubMed ID: 31986050 [TBL] [Abstract][Full Text] [Related]
2. In Vitro-In Vivo Correlation in Cocrystal Dissolution: Consideration of Drug Release Profiles Based on Coformer Dissolution and Absorption Behavior. Kataoka M; Minami K; Takagi T; Amidon GE; Yamashita S Mol Pharm; 2021 Nov; 18(11):4122-4130. PubMed ID: 34618448 [TBL] [Abstract][Full Text] [Related]
3. Ketoconazole-p aminobenzoic cocrystal, an improved antimycotic drug formulation, does not induce skin sensitization on the skin of BALBc mice. Danescu S; Filip GA; Moldovan R; Olteanu D; Nagy A; Filip X; Martin F; Kacso I; Baldea I Inflammopharmacology; 2021 Jun; 29(3):721-733. PubMed ID: 34086140 [TBL] [Abstract][Full Text] [Related]
4. Control of Dissolution and Supersaturation/Precipitation of Poorly Water-Soluble Drugs from Cocrystals Based on Solubility Products: A Case Study with a Ketoconazole Cocrystal. Kataoka M; Yonehara A; Minami K; Takagi T; Yamashita S Mol Pharm; 2023 Aug; 20(8):4100-4107. PubMed ID: 37354097 [TBL] [Abstract][Full Text] [Related]
5. Surface Solid Dispersion of Ketoconazole on Trehalose Dihydrate using Spray Drying to Achieve Enhanced Dissolution Rate. Weecharangsan W; Lee RJ AAPS PharmSciTech; 2024 Sep; 25(7):220. PubMed ID: 39313719 [TBL] [Abstract][Full Text] [Related]
6. Preparation, characterization, and scale-up of ketoconazole with enhanced dissolution and bioavailability. Elder EJ; Evans JC; Scherzer BD; Hitt JE; Kupperblatt GB; Saghir SA; Markham DA Drug Dev Ind Pharm; 2007 Jul; 33(7):755-65. PubMed ID: 17654024 [TBL] [Abstract][Full Text] [Related]
8. In vitro and in vivo evaluation of oral tablet formulations prepared with ketoconazole and hydroxypropyl-beta-cyclodextrin. Taneri F; Ozcan I; Guneri T Drug Deliv; 2010 Apr; 17(3):152-7. PubMed ID: 20148713 [TBL] [Abstract][Full Text] [Related]
9. Ketoconazole-loaded poly-(lactic acid) nanoparticles: Characterization and improvement of antifungal efficacy in vitro against Candida and dermatophytes. Endo EH; Makimori RY; Companhoni MVP; Ueda-Nakamura T; Nakamura CV; Dias Filho BP J Mycol Med; 2020 Sep; 30(3):101003. PubMed ID: 32586733 [TBL] [Abstract][Full Text] [Related]
10. Mechanistic Analysis of Cocrystal Dissolution, Surface pH, and Dissolution Advantage as a Guide for Rational Selection. Cao F; Rodriguez-Hornedo N; Amidon GE J Pharm Sci; 2019 Jan; 108(1):243-251. PubMed ID: 30278187 [TBL] [Abstract][Full Text] [Related]
11. Pharmaceutical Cocrystal: A Novel Approach to Tailor the Biopharmaceutical Properties of a Poorly Water Soluble Drug. Srivastava D; Fatima Z; Kaur CD; Tulsankar SL; Nashik SS; Rizvi DA Recent Pat Drug Deliv Formul; 2019; 13(1):62-69. PubMed ID: 30848223 [TBL] [Abstract][Full Text] [Related]
12. Influence of Coformer Stoichiometric Ratio on Pharmaceutical Cocrystal Dissolution: Three Cocrystals of Carbamazepine/4-Aminobenzoic Acid. Li Z; Matzger AJ Mol Pharm; 2016 Mar; 13(3):990-5. PubMed ID: 26837376 [TBL] [Abstract][Full Text] [Related]
13. Effects of Manufacturing Methods on Dissolution and Absorption of Ketoconazole in the Presence of Organic Acid as a pH Modifier. Adachi M; Hinatsu Y; Kusamori K; Katsumi H; Sakane T; Nakatani M; Wada K; Yamamoto A AAPS PharmSciTech; 2017 May; 18(4):1203-1212. PubMed ID: 27431914 [TBL] [Abstract][Full Text] [Related]
14. Development of direct compression Acetazolamide tablet with improved bioavailability in healthy human volunteers enabled by cocrystallization with p-Aminobenzoic acid. Kumari N; Roy P; Roy S; Wang C; Das S; Pandey N; Mondal SK; Bose A; Sun CC; Ghosh A Int J Pharm; 2024 Mar; 652():123793. PubMed ID: 38195033 [TBL] [Abstract][Full Text] [Related]
15. Potential use of phospholipids in combination with hydrophilic carriers for enhancement of the dissolution and oral bioavailability of imidazole antifungal Class II drugs. Abu Hashim II; Ghazy NF; El-Shabouri MH Pharmazie; 2015 Nov; 70(11):706-15. PubMed ID: 26790186 [TBL] [Abstract][Full Text] [Related]
16. In vitro-in vivo correlation of the effect of supersaturation on the intestinal absorption of BCS Class 2 drugs. Higashino H; Hasegawa T; Yamamoto M; Matsui R; Masaoka Y; Kataoka M; Sakuma S; Yamashita S Mol Pharm; 2014 Mar; 11(3):746-54. PubMed ID: 24460473 [TBL] [Abstract][Full Text] [Related]
18. Improved dissolution and absorption of ketoconazole in the presence of organic acids as pH-modifiers. Adachi M; Hinatsu Y; Kusamori K; Katsumi H; Sakane T; Nakatani M; Wada K; Yamamoto A Eur J Pharm Sci; 2015 Aug; 76():225-30. PubMed ID: 25988287 [TBL] [Abstract][Full Text] [Related]
19. Use of a glutaric acid cocrystal to improve oral bioavailability of a low solubility API. McNamara DP; Childs SL; Giordano J; Iarriccio A; Cassidy J; Shet MS; Mannion R; O'Donnell E; Park A Pharm Res; 2006 Aug; 23(8):1888-97. PubMed ID: 16832611 [TBL] [Abstract][Full Text] [Related]
20. Effect of solubilizing and microemulsifying excipients in polyethylene glycol 6000 solid dispersion on enhanced dissolution and bioavailability of ketoconazole. Heo MY; Piao ZZ; Kim TW; Cao QR; Kim A; Lee BJ Arch Pharm Res; 2005 May; 28(5):604-11. PubMed ID: 15974450 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]